Insulin resistance as the underlying cause for the metabolic syndrome

被引:166
作者
Lann, Danielle [1 ]
LeRoith, Derek [1 ]
机构
[1] Mt Sinai Hosp, Mt Sinai Sch Med, Dept Med, Div Endocrinol Diabet & Bone Dis, New York, NY 10029 USA
关键词
D O I
10.1016/j.mcna.2007.06.012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Classically, the metabolic syndrome is characterized as group of pathologies including visceral obesity, hypertension, dyslipidemia, and impaired glucose tolerance. It is now realized that insulin resistance plays a principal role in initiating and perpetuating the pathologic manifestations of the metabolic syndrome. A more in-depth understanding of the basic pathophysiologic mechanisms underlying insulin resistance may aid clinicians in treating and possibly delaying or even preventing the onset of the metabolic syndrome and its complications. This article outlines how abnormal insulin signaling and secretion, impaired glucose disposal, lipotoxicity, and proinflammatory cytokines exacerbate insulin resistance and result in the perturbations of the metabolic syndrome.
引用
收藏
页码:1063 / +
页数:16
相关论文
共 87 条
[1]   FoxOs at the crossroads of cellular metabolism, differentiation, and transformation [J].
Accili, D ;
Arden, KC .
CELL, 2004, 117 (04) :421-426
[2]   Pathophysiological role of leptin in obesity-related hypertension [J].
Aizawa-Abe, M ;
Ogawa, Y ;
Masuzaki, H ;
Ebihara, K ;
Satoh, N ;
Iwai, H ;
Matsuoka, N ;
Hayashi, T ;
Hosoda, K ;
Inoue, G ;
Yoshimasa, Y ;
Nakao, K .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (09) :1243-1252
[3]   The effect of sensitisation to insulin with pioglitazone on fasting and postprandial lipid metabolism, lipoprotein modification by lipases, and lipid transfer activities in type 2 diabetic patients [J].
Al Majali, K ;
Cooper, MB ;
Staels, B ;
Luc, G ;
Taskinen, MR ;
Betteridge, DJ .
DIABETOLOGIA, 2006, 49 (03) :527-537
[4]   Enhanced insulin-stimulated glycogen synthesis in response to insulin, metformin or rosiglitazone is associated with increased mRNA expression of GLUT4 and peroxisomal proliferator activator receptor gamma co-activator 1 [J].
Al-Khalili, L ;
Forsgren, M ;
Kannisto, K ;
Zierath, J ;
Lönnqvist, F ;
Krook, A .
DIABETOLOGIA, 2005, 48 (06) :1173-1179
[5]   Foxo1 mediates insulin action on apoC-III and triglyceride metabolism [J].
Altomonte, J ;
Cong, L ;
Harbaran, S ;
Richter, A ;
Xu, J ;
Meseck, M ;
Dong, HJH .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (10) :1493-1503
[6]   Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity [J].
Arita, Y ;
Kihara, S ;
Ouchi, N ;
Takahashi, M ;
Maeda, K ;
Miyagawa, J ;
Hotta, K ;
Shimomura, I ;
Nakamura, T ;
Miyaoka, K ;
Kuriyama, H ;
Nishida, M ;
Yamashita, S ;
Okubo, K ;
Matsubara, K ;
Muraguchi, M ;
Ohmoto, Y ;
Funahashi, T ;
Matsuzawa, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (01) :79-83
[7]   IKK-β links inflammation to obesity-induced insulin resistance [J].
Arkan, MC ;
Hevener, AL ;
Greten, FR ;
Maeda, S ;
Li, ZW ;
Long, JM ;
Wynshaw-Boris, A ;
Poli, G ;
Olefsky, J ;
Karin, M .
NATURE MEDICINE, 2005, 11 (02) :191-198
[8]   Role of blood flow in the regulation of muscle glucose uptake [J].
Baron, AD ;
Clark, MG .
ANNUAL REVIEW OF NUTRITION, 1997, 17 :487-499
[9]   Dose-response effect of elevated plasma free fatty acid on insulin signaling [J].
Belfort, R ;
Mandarino, L ;
Kashyap, S ;
Wirfel, K ;
Pratipanawatr, T ;
Berria, R ;
DeFronzo, RA ;
Cusi, K .
DIABETES, 2005, 54 (06) :1640-1648
[10]   From mice to men: Insights into the insulin resistance syndromes [J].
Biddinger, SB ;
Kahn, CR .
ANNUAL REVIEW OF PHYSIOLOGY, 2006, 68 :123-158